Literature DB >> 16076987

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

Jeanne M Clark1, Amir R A Alkhuraishi, Steven F Solga, Patricia Alli, Anna Mae Diehl, Thomas H Magnuson.   

Abstract

OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in the United States and is prevalent in morbidly obese patients. While weight loss and treatment of risk factors are recommended, the reported effects of bariatric surgery on NAFLD are mixed. RESEARCH METHODS AND PROCEDURES: We examined liver histology at the time of Roux-en-Y gastric bypass surgery and at elective incisional hernia repair after weight loss for 16 patients at one center. Slides were read by one pathologist, blinded to clinical data, using the Brunt criteria. Clinical and laboratory data were extracted from chart review. Alcohol use was ascertained by two interviews.
RESULTS: At baseline, the mean age was 44 years, 50% were women, 88% were white, and the mean BMI was 51 kg/m2. None had significant alcohol use. On initial biopsy, all patients showed steatosis, 94% had inflammation, 88% had ballooning degeneration, 88% had perisinusoidal fibrosis, and 81% had portal fibrosis. The mean time between the two biopsies was 305 +/- 131 (SD) days. The mean weight loss was 118 +/- 29 lb. Steatosis improved in 15 of 16 patients, with resolution in 13. Twelve of 15 patients with inflammation at baseline showed improvement, and 12 of 14 showed less ballooning. Six of 14 patients with perisinusoidal fibrosis and 6 of 13 with portal fibrosis showed improvement. No patient had worsening of steatosis, inflammation, ballooning, or fibrosis. DISCUSSION: Our study shows improvement in all of the histological features of NAFLD after Roux-en-Y gastric bypass surgery-induced weight loss, despite significant histopathology at baseline and substantial weight loss.

Entities:  

Mesh:

Year:  2005        PMID: 16076987     DOI: 10.1038/oby.2005.140

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  51 in total

1.  Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Jau-Chung Hwang; Hung Chiang; Chi-Yang Chang; Ching-Tai Lee; Ming-Lung Yu; Jaw-Town Lin
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.

Authors:  Palanivelu Praveenraj; Rachel M Gomes; Saravana Kumar; Purushothaman Karthikeyan; Annapoorni Shankar; Ramakrishnan Parthasarathi; Palanisamy Senthilnathan; Subbiah Rajapandian; Chinnusamy Palanivelu
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

3.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 4.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

5.  Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.

Authors:  Narendra S Choudhary; Neeraj Saraf; Sanjiv Saigal; Dheeraj Gautam; Lipika Lipi; Amit Rastogi; Sanjay Goja; Palat B Menon; Prashant Bhangui; Sumana K Ramchandra; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2015-04-21

6.  Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.

Authors:  Ming-Lun Han; Wei-Jei Lee; Jung-Chien Chen; Kong-Han Ser; Shu-Chun Chen; Yi-Chih Lee
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

7.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 8.  The effect of bariatric surgeries on nonalcoholic fatty liver disease.

Authors:  Mazen Hassanian; Amnah Al-Mulhim; Atheer Al-Sabhan; Shaden Al-Amro; Fahad Bamehriz; Ayman Abdo; Hisham Al Khalidi; Tamader A Aldoheyan
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

Review 9.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

10.  Nonalcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients.

Authors:  Satoru Kakizaki; Daichi Takizawa; Yuichi Yamazaki; Yuka Nakajima; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori; Kazunori Kasama
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.